Hints and tips:
...Morningstar strategist Robby Greengold earlier this month pointed to the “compelling” nature of the themes that the Innovation fund invests in — artificial intelligence, blockchain technology, genetic technology...
...Genetic testing company 23andMe has grand ambitions for personalised healthcare....
...Following success in some small initial trials, Grail and an Indian company, Datar Cancer Genetics, are already selling MCED tests to the public....
...The test works by using genetic sequencing and artificial intelligence to scan a certain type of DNA (cell-free DNA) found in people’s blood for changes caused by cancer cells....
...Reliance has recently invested in healthcare companies including genetics group Strand Life Sciences, after buying a majority stake in pharma sales company Netmeds in 2020....
...Ark is a big proponent of “precision” medicine, the idea that patients can be matched with drugs targeting the specific genetic drivers of their disease....
...Illumina, the genetic sequencing biotech, has taken the rare step of finalising its $8bn acquisition of Grail, the cancer screening company backed by Jeff Bezos and Bill Gates, despite still being under...
...One thing to start: a blank-cheque company backed by Richard Branson’s Virgin Group is in talks to merge with 23andMe, in a deal that would bring the genetics testing company on to public markets at a value...
...Today we want to focus on Blackstone and genetics. Well, specifically your DNA....
...Boston area start-up Moderna was quickly off to the races and an early winner in finding a vaccine through its work on viral genetics....
...A Book of Life by 2030 Scientists are racing to put together what they call the “Book of Life”: the genetic sequences of all complex species on the planet and the relationships between them....
...Talking about Google’s work to improve the accuracy of mammograms by using medical records and genetic information, he said: “There is incredible power in the ability not only with the data, but combining...
...A deadlier variant could occur in thematic index investing where some crazy idea for a sexy fund — a mutant combination, say, of blockchain, genetics and artificial intelligence in the title — ends up with...
...But a more precise understanding of biology has led pharmaceutical companies to focus research and development efforts on treatments for rarer diseases, often aimed at small sub groups with a particular genetic...
...submission for Lynparza, a drug which AstraZeneca now co-owns in a 50:50 partnership with Merck, the US drug company, to treat breast cancer that spread elsewhere in the body for patients with a particular genetic...
...Scientists have for the first time corrected a genetic defect in newly created human embryos, demonstrating that contentious “gene editing” technology could prevent the transmission of some inherited diseases...
...In a sign that regulators in Washington are just as alive to such issues, the US Department of Justice sued Deere & Co last week to block its purchase of Monsanto’s Precision Planting LLC equipment unit,...
...Its most advanced programme is focused on a rare genetic condition that causes blindness. The science is at a very early stage and is being tested on individual cells in a laboratory....
...Photographs: Giant screen films © 2012 D3D Ice Age, LLC; Getty Images...
...This could eventually open the way for people to be able to buy tests for a range of genetic defects....
...Google has invested in two companies that aim to do their own research on the back of the proliferation of medical data: 23andMe, a DNA-testing company that has a bank of genetic information from the 850,000...
...As one of the world’s emerging corn import heavyweights, however, China’s stance on genetic modification has the potential to transform agricultural markets....
...Chicago experiment and the 2013 comet impact simulation provide building blocks for life, neither explains how nature linked these together into proteins – or how self-replicating systems came to encode genetic...
...Genetic manipulation has given the mice a substantial part of the human immune system – all in the cause of making better medicines....
...Part of this behaviour is genetic. One of the supposed Wall Street truisms is that the great firms stay out of the limelight and shun press inquiries....
International Edition